pI: 11.2314 |
Length (AA): 148 |
MW (Da): 16723 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 147 | 1vq8 (L) | 2 | 143 | 29.00 | 0 | 0.92 | 1.06 | 1.51 |
35 | 146 | 1vq8 (O) | 19 | 98 | 25.00 | 0 | 0.97 | 0.6 | 0.47 |
5 | 147 | 1vq8 (L) | 1 | 143 | 21.00 | 0.000000000028 | 0.37 | 1.04562 | 0.98 |
8 | 142 | 1vq8 (L) | 2 | 138 | 32.00 | 0.0000047 | 0.78 | 1.04046 | 1.34 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst, Ring, Sporozoite, Female Gametocyte, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_127016)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G70600 | 60S ribosomal protein L27a-3 |
Arabidopsis thaliana | AT1G23290 | 60S ribosomal protein L27a-2 |
Babesia bovis | BBOV_III006560 | ribosomal protein L15, putative |
Brugia malayi | Bm1_04910 | 60S ribosomal protein L27a |
Caenorhabditis elegans | CELE_Y37E3.8 | Protein Y37E3.8, isoform A |
Cryptosporidium hominis | Chro.30443 | ribosomal protein L22 |
Cryptosporidium parvum | cgd3_3930 | 60S ribosomal protein L27A or L27a |
Dictyostelium discoideum | DDB_G0292388 | S60 ribosomal protein L27a |
Drosophila melanogaster | Dmel_CG15442 | Ribosomal protein L27A |
Entamoeba histolytica | EHI_169100 | ribosomal protein L27a, putative |
Entamoeba histolytica | EHI_069490 | ribosomal protein L27a, putative |
Entamoeba histolytica | EHI_192090 | ribosomal protein L27a, putative |
Giardia lamblia | GL50803_16310 | Ribosomal protein L27a |
Homo sapiens | ENSG00000166441 | ribosomal protein L27a |
Leishmania braziliensis | LbrM.34.3740 | 60S ribosomal protein L27A/L29, putative |
Leishmania braziliensis | LbrM.34.3760 | 60S ribosomal protein L27A/L29, putative |
Leishmania donovani | LdBPK_353810.1 | 60S ribosomal protein L27A/L29, putative |
Leishmania infantum | LinJ.35.3830 | 60S ribosomal protein L27A/L29, putative |
Leishmania infantum | LinJ.35.3810 | 60S ribosomal protein L27A/L29, putative |
Leishmania major | LmjF.35.3760 | 60S ribosomal protein L27A/L29, putative |
Leishmania major | LmjF.35.3780 | 60S ribosomal protein L27A/L29, putative |
Leishmania mexicana | LmxM.34.3760 | 60S ribosomal protein L27A/L29, putative |
Leishmania mexicana | LmxM.34.3780 | 60S ribosomal protein L27A/L29, putative |
Loa Loa (eye worm) | LOAG_09561 | 60S ribosomal protein L27a |
Mus musculus | 546052 | predicted gene 5908 |
Mus musculus | ENSMUSG00000046364 | ribosomal protein L27A |
Neospora caninum | NCLIV_054570 | 60S ribosomal protein Ll28B 27a, related |
Oryza sativa | 4328472 | Os02g0175600 |
Oryza sativa | 4333083 | Os03g0408300 |
Oryza sativa | 4343884 | Os07g0613200 |
Onchocerca volvulus | OVOC1439 | 60S ribosomal protein L27a homolog |
Plasmodium berghei | PBANKA_1117500 | ribosomal protein L27a, putative |
Plasmodium falciparum | PF3D7_0618300 | 60S ribosomal protein L27a, putative |
Plasmodium knowlesi | PKNH_1132100 | 60S ribosomal protein L27a, putative |
Plasmodium vivax | PVX_114040 | 60S ribosomal protein L27a, putative |
Plasmodium yoelii | PY03375 | ribosomal protein L27a |
Saccharomyces cerevisiae | YGL103W | ribosomal 60S subunit protein L28 |
Schmidtea mediterranea | mk4.037030.00 | 60S ribosomal protein L27a |
Trypanosoma brucei gambiense | Tbg972.9.6830 | 60S ribosomal protein L27a,60S ribosomal protein L28,60S ribosomal protein L29, putative |
Trypanosoma brucei gambiense | Tbg972.9.6810 | 60S ribosomal protein L27a,60S ribosomal protein L28,60S ribosomal protein L29 |
Trypanosoma brucei | Tb927.9.11490 | 60S ribosomal protein L29 |
Trypanosoma brucei | Tb427tmp.211.2650 | 60S ribosomal protein L27a |
Trypanosoma congolense | TcIL3000_0_56640 | 60S ribosomal protein L27a |
Trypanosoma cruzi | TcCLB.508461.510 | 60S ribosomal protein L27A/L29, putative |
Trypanosoma cruzi | TcCLB.508461.500 | 60S ribosomal protein L27A/L29, putative |
Toxoplasma gondii | TGME49_310490 | ribosomal protein RPL27A |
Theileria parva | TP02_0317 | 60S ribosomal protein L27a, putative |
Trichomonas vaginalis | TVAG_143790 | 60S ribosomal protein L27a, putative |
Trichomonas vaginalis | TVAG_121550 | 60S ribosomal protein L27a, putative |
Trichomonas vaginalis | TVAG_401890 | 60S ribosomal protein L27a, putative |
Trichomonas vaginalis | TVAG_346410 | 60S ribosomal protein L27a, putative |
Trichomonas vaginalis | TVAG_199230 | 60S ribosomal protein L27a, putative |
Trichomonas vaginalis | TVAG_300490 | 60S ribosomal protein L27a, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.2650 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.2650 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.2650 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.2650 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y37E3.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
YGL103W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_310490 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.